JPMORGAN CHASE & CO - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.94 and the average weighting 1.5%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$01,5830.0%0.00%
Q2 2022$0
-100.0%
1,583
-97.2%
0.00%
Q1 2022$77,000
+5.5%
55,864
-8.3%
0.00%
Q4 2021$73,000
-62.6%
60,928
-17.9%
0.00%
Q3 2021$195,000
-55.0%
74,199
-9.4%
0.00%
Q2 2021$433,000
-18.8%
81,865
+3.3%
0.00%
Q1 2021$533,000
-6.0%
79,261
-5.3%
0.00%
Q4 2020$567,000
-58.1%
83,658
-51.0%
0.00%
Q3 2020$1,354,000
+24.6%
170,711
+64.9%
0.00%
Q2 2020$1,087,000
+37.2%
103,494
+14.9%
0.00%
Q1 2020$792,000
-2.3%
90,112
-59.0%
0.00%
Q4 2019$811,000
-18.7%
219,971
-16.1%
0.00%
Q3 2019$997,000
-33.9%
262,060
+2.1%
0.00%
Q2 2019$1,509,000
-31.0%
256,698
-2.9%
0.00%
Q1 2019$2,186,000
+74.3%
264,243
+3.1%
0.00%
Q4 2018$1,254,000
-20.6%
256,389
+60.2%
0.00%
Q3 2018$1,580,000
-1.2%
160,080
+37.4%
0.00%
Q2 2018$1,599,000
-49.8%
116,481
-42.1%
0.00%
-100.0%
Q1 2018$3,184,000
-23.3%
201,130
-10.5%
0.00%0.0%
Q4 2017$4,153,000
+2.9%
224,628
+28.4%
0.00%0.0%
Q3 2017$4,037,000174,9060.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders